The short answer
There is not enough direct evidence that glucomannan reduces repaglinide absorption. Do not alter the medicine’s meal schedule based on a general fiber warning.
What this answer covers
Oral glucomannan fiber; viscosity, dose and product formulation matter. Other fibers are not interchangeable.
- Supplement or preparation
- Glucomannan
- Medication ingredient
- repaglinide
What the laboratory evidence tested
One experiment tested dietary fibers with glimepiride and two biguanides. Free drug changed depending on the medicine, fiber and solution. Repaglinide was not tested.
Why this is not a clinical absorption result
A laboratory mixture does not measure how much repaglinide reaches the blood in a person or whether glucose control worsens. The evidence does not establish a universal fiber separation interval.
Bring the actual product for review
Show the pharmacist the glucomannan amount, other ingredients and how it is taken with meals. Keep a record of glucose changes rather than assuming a change is caused by reduced drug absorption.
Keep the prescribed medicine plan
Take repaglinide within thirty minutes before meals as prescribed and skip its dose when a meal is skipped. Review supplement changes with the prescriber instead of inventing a separation interval or adjusting the medicine yourself.
Watch for low blood sugar
Follow your existing glucose-monitoring and low-blood-sugar treatment plan. New sweating, shakiness, hunger or confusion warrants a glucose check when possible. Severe confusion, a seizure or inability to swallow safely needs emergency help.
Evidence and practical considerations
Absorption & effectiveness
The current repaglinide absorption-reduction claim remains unproven. An original laboratory comparison found drug- and medium-dependent effects for glimepiride, metformin and buformin, without testing repaglinide.
- Exact scope
- Oral glucomannan fiber; viscosity, dose and product formulation matter. Other fibers are not interchangeable. with Exact repaglinide oral tablets. Exact RxNorm IN73044 oral repaglinide; CYP2C8, CYP3A4 and transporters must not be equated with nateglinide pathways.
- Medication form and route
- oral
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- No exact human repaglinide study or protective interval identified. Laboratory binding of another drug cannot establish this pair or treatment failure.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed repaglinide.
Insulin secretagogue with hypoglycemia risk; within thirty minutes before meals and skip dose with skipped meal; nicotinic acid may reduce glucose-lowering effect, salicylates may increase it.
How this applies: Exact RxNorm IN73044 oral repaglinide; CYP2C8, CYP3A4 and transporters must not be equated with nateglinide pathways.
No universal supplement dose, interval, event rate or untested formulation equivalence.
Source 2: Original laboratory study
jstage.jst.go.jp · Source check Sep 10, 2026
Population: Drug-fiber solutions, not patients.
Free glimepiride decreased in this experiment.
How this applies: Original in vitro glimepiride, buformin and metformin comparison; no repaglinide assay or human spacing rule.
No patient pharmacokinetics, glucose outcomes or protective interval measured; effects varied by drug, fiber and medium.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Research summary published | |
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. |
Article revision: a29d877cfce9b570
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.